Advanced or Metastatic Solid Tumors Completed Phase 1 Trials for Bortezomib (DB00188)

IndicationStatusPhase
DBCOND0034454 (Advanced or Metastatic Solid Tumors)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02220049Dose Escalation of Velcade Daily Dose in Patients With Solid TumorsTreatment